Brief: Acelrx Pharmaceuticals Announces Publication Of Clinical Data With Use Of Sublingual Sufentanil
15/12/2021 13:39
Dec 15 (Reuters) - AcelRx Pharmaceuticals Inc ACRX.O :
* ACELRX PHARMACEUTICALS ANNOUNCES PUBLICATION OF CLINICAL DATA SHOWING
REDUCED
HOSPITAL LENGTH OF STAY AND REDUCED OPIOID UTILIZATION WITH USE OF SUBLINGUAL
SUFENTANIL IN TOTAL JOINT REPLACEMENT SURGERY
Source text for Eikon: ID:nPn9YrcKXa
Further company coverage: ACRX.O
Recent news on Talphera
See all newsTalphera Inc reports results for the quarter ended June 30 - Earnings Summary
Talphera Inc expected to post a loss of 7 cents a share - Earnings Preview
Talphera Q1 net loss narrows as costs rise on higher development spending
Talphera Q4 net loss widens as operating expenses rise
Brief: Talphera Announces 50% Enrollment Milestone In Ongoing Nephro-Crrt Registrational Trial